Clinical Trial Update: ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of veliparib (ABT-888) in combination with temozolomide for metastatic breast cancer and BRCA-mutated breast cancers has completed, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Temozolomide (Temozolomide)
• Veliparib (ABT-888) (veliparib)

Snippet

Sponsor: Steven J Isakoff, MD, PhD | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-03-14